Skip to Main Content

Author Details

Andrea Sitlinger
Duke University School of Medicine
2011
21
11
PMIDPaper TitleJournal TitlePublished Year
36096873Effects of high-intensity interval training on health-related quality of life in chronic lymphocytic leukemia: A pilot study.J Geriatr Oncol2023
35992862Associations of clinical and circulating metabolic biomarkers with low physical fitness and function in adults with chronic lymphocytic leukemia.Front Oncol2022
35818559Cardiometabolic Comorbidities in Cancer Survivors: <i>JACC: CardioOncology</i> State-of-the-Art Review.JACC CardioOncol2022
35873215Racial differences in venous thromboembolism: A surveillance program in Durham County, North Carolina.Res Pract Thromb Haemost2022
33259589Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.Blood2021
34848750A pilot study of high-intensity interval training in older adults with treatment naïve chronic lymphocytic leukemia.Sci Rep2021
34064804Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL).Cells2021
34168050The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.Clin Cancer Res2021
32079693Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.Haematologica2021
32343800Impact of exercise on the immune system and outcomes in hematologic malignancies.Blood Adv2020
31982152A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: Results from a multicenter retrospective cohort study.Leuk Res2020
32841336Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents.Blood Adv2020
32198151Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy.Clin Cancer Res2020
30553719Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer.J Geriatr Oncol2019
31365941Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.Appl Clin Inform2019
31101647A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.Blood Adv2019
31004001Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.Clin Cancer Res2019
29219913With Colorectal Cancer Treatment, Physical Toxicity Is Not the Only Concern.Dis Colon Rectum2018
30213412Health-Related Quality of Life: The Impact on Morbidity and Mortality.Surg Oncol Clin N Am2018
29880613Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.Haematologica2018
21684390Preliminary program evaluation of emergency department HIV prevention counseling.Ann Emerg Med2011
  • 1 - 21 of 21

Recommended Authors

Clark DuMontier
Brigham and Women's Hospital
Career Start Year 2013
Number of shared co-authors 0
Matthew A Hathcock
Mayo Clinic
Career Start Year 2013
Number of shared co-authors 0
Melissa C Larson
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Yunfeng Dai
Colleges of Medicine, University of Florida
Career Start Year 2009
Number of shared co-authors 0
Kelley M Kidwell
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 1
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 0
Angelina D Tan
Mayo Clinic
Career Start Year 2006
Number of shared co-authors 0
Areej El-Jawahri
Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Kathryn J Ruddy
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Minya Pu
University of California
Career Start Year 2003
Number of shared co-authors 0
Nora Horick
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 0
Tait D Shanafelt
Stanford Cancer Institute, Stanford University
Career Start Year 2002
Number of shared co-authors 0
Susan Geyer
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 0
Kathleen J Yost
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 0
Lee W Jones
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year 1997
Number of shared co-authors 0
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 0
Arash Naeim
University of California los angeles
Career Start Year 1994
Number of shared co-authors 0
Paul J Novotny
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Jeffrey Peppercorn
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1993
Number of shared co-authors 1
Smita Bhatia
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 0
Jeff A Sloan
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 0
Robert A Oster
University of Alabama at Birmingham
Career Start Year 1988
Number of shared co-authors 1
Motomi Mori
St Jude Children's Research Hospital.
Career Start Year 1988
Number of shared co-authors 2
Eva M Lepisto
Dana-Farber Cancer Institute and Harvard Medical School
Career Start Year 1987
Number of shared co-authors 0
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Brad H Pollock
University of California davis
Career Start Year 1983
Number of shared co-authors 1

Collaborators

Thomas L Ortel
Duke University Medical Center
Co-authored papers 2
Alexey V Danilov
City of Hope National Medical Center
Co-authored papers 2
Hayden B Bosworth
Duke University School of Medicine
Co-authored papers 2
Kimberly W Hart
Vanderbilt University Medical Center
Co-authored papers 1
Christopher J Lindsell
Duke University
Co-authored papers 1
Andy Kaempf
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
David L Corcoran
The University of North Carolina at Chapel Hill
Co-authored papers 1
Diane B Wayne
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Paul K Marcom
Co-authored papers 1
Alexander T Trott
University of Cincinnati College of Medicine
Co-authored papers 1
Michael S Lyons
The Ohio State University College of Medicine
Co-authored papers 1
Suman Kambhampati
Co-authored papers 1
Andrew H Ruffner
University of Cincinnati College of Medicine
Co-authored papers 1
Carl J Fichtenbaum
University of Cincinnati
Co-authored papers 1
Geoffrey Shouse
City of Hope National Medical Center
Co-authored papers 1
Release 1.2